Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Prof. Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Mazandaran University of Medical Sciences, Sari, Iran

Dr. Hamidreza Mohammadi is a researcher specializing in toxicology, pharmacology, and nanomedicine, with extensive work focused on the toxicological and therapeutic applications of nanomaterials. His research spans multiple domains including nanotoxicology, polymer therapeutics, clinical and food toxicology, and the development of safer nanopharmaceuticals. He has contributed to advancing the understanding of how engineered nanomaterials interact with biological systems, emphasizing risk assessment, cellular mechanisms of toxicity, and strategies for biocompatibility improvement. Dr. Mohammadi’s studies also explore the design of polymer-based drug delivery systems with enhanced therapeutic efficacy and reduced side effects. His work integrates experimental and applied toxicology to bridge laboratory research with clinical practice, contributing to public health and safety in pharmacological sciences. With interdisciplinary expertise covering both environmental and clinical toxicology, his research aligns with global priorities in nanomedicine innovation and toxicological risk evaluation. His scholarly efforts continue to support the development of next-generation nanotherapeutics with optimized pharmacokinetics and minimized toxic responses, reinforcing the importance of safe and sustainable nanotechnology in medical and pharmaceutical applications.

Profile: Orcid

Featured Publications:

Mokhtari Azad, T., Mohammadi, H., Moosavi, A., Saadatmand, Z., & Nategh, R. (2004). Influenza surveillance in the Islamic Republic of Iran from 1991 to 2001. Eastern Mediterranean Health Journal, 10(3), 315–321.

Cheraghali, A. M., Mohammadi, H. R., Amirahmadi, M., Yazdanpanah, H., Abouhossain, G., & Zamanian, F. (2005). Incidence of patulin contamination in apple juice produced in Iran. Food Control, 16(2), 165–167.

Shafiee, H., Mohammadi, H., Rezayat, S. M., Hosseini, A., Baeeri, M., & Hassani, S. (2010). Prevention of malathion-induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium-carrying nanoparticle. Toxicology Mechanisms and Methods, 20(9), 538–543.

Mohammadi, H., Karimi, G., Rezayat, S. M., Reza, A., Shafiee, H., & Nikfar, S. (2011). Benefit of nanocarrier of magnetic magnesium in rat malathion-induced toxicity and cardiac failure using non-invasive monitoring of electrocardiogram and blood pressure. Toxicology and Industrial Health, 27(5), 417–429.

Soltani, M., Shetab-Boushehri, S. F., Mohammadi, H., & Shetab-Boushehri, S. V. (2013). Proposing boric acid as an antidote for aluminium phosphide poisoning by investigation of the chemical reaction between boric acid and phosphine. Journal of Medical Hypotheses and Ideas, 7(1), 21–24.

Mohammad Shahangir Biswas | Cellular Toxicity | Best Researcher Award

Dr. Mohammad Shahangir Biswas | Cellular Toxicity | Best Researcher Award

Dr. Mohammad Shahangir Biswas | University of Science & Technology Chittagong | Bangladesh

Dr. Mohammad Shahangir Biswas is a distinguished academician and researcher in the fields of Biochemistry, Biotechnology, and Public Health, currently serving as an Assistant Professor at the University of Science and Technology Chittagong (USTC), Bangladesh. He worked as a Postdoctoral Research Associate at the University of Wisconsin-Madison, USA. His academic and research journey reflects a dedication to global health issues, molecular biology, and neurophysiology. Previously, he served as Assistant Professor at Khwaja Yunus Ali University. He has co-authored more than 48 scientific publications, including multiple first-author articles in The Lancet and other Q1 journals. With international exposure and extensive research collaborations, he brings a strong commitment to scientific excellence. Dr. Biswas is fluent in English, speaks Japanese (basic), and is a native speaker of Bangla. He is passionate about public health advancement, biomedical research, and mentoring the next generation of scientists.

Publication Profiles:

Scopus
Orcid

Education:

Dr. Biswas earned his Ph.D. in Biochemistry/Medical Science from Tokyo Medical and Dental University, supported by the prestigious MEXT Scholarship. He later completed a Postdoctoral Fellowship at the University of Wisconsin-Madison, USA, contributing to advanced research in public health and neurophysiology. Prior to his doctoral studies, he obtained his M.Sc. (Thesis) and B.Sc. (Hons.) degrees in Biochemistry and Molecular Biology from the University of Rajshahi, Bangladesh. His early academic excellence earned him multiple scholarships and positioned him for a strong career in scientific research. This strong educational foundation, combined with global exposure, has equipped him with expertise in molecular biology, public health research, and biotechnological innovation. Dr. Biswas continues to use his academic training to lead impactful research, particularly in disease burden analysis and biomedical therapeutics.

Experience:

Dr. Mohammad Shahangir Biswas brings a diverse academic and research background spanning over a decade. He served as Assistant Professor at Khwaja Yunus Ali University and later joined USTC as Assistant Professor, soon to be active as an Associate Professor. He conducted impactful postdoctoral research at the University of Wisconsin-Madison, contributing to global public health research initiatives. His teaching and research cover Biochemistry, Biotechnology, Neurophysiology, and Public Health. In addition to his teaching roles, Dr. Biswas is a Senior Collaborator in the Global Burden of Disease (GBD) Study, contributing to several high-impact international publications. His strong leadership, grant acquisition, and mentoring skills have made him an influential figure in Bangladesh’s biomedical research landscape. He remains dedicated to fostering collaborative research and academic excellence both locally and internationally.

Awards and Honors:

Dr. Biswas has received numerous awards and recognitions throughout his academic journey. Notably, he was awarded the Japanese MEXT Scholarship for his Ph.D. studies in Japan—a highly competitive and prestigious international award. His undergraduate and postgraduate achievements at the University of Rajshahi were recognized with merit-based scholarships. Additionally, he received an R&D Grant from the Ministry of Science and Technology, Bangladesh, for conducting impactful research. His research contributions to major international collaborations such as the Global Burden of Disease Study have further established his credibility and excellence in global health research. His work has been accepted in top-tier journals including The Lancet and JACC, cementing his role as a leading researcher from Bangladesh on the global stage. These honors reflect his dedication, academic brilliance, and contributions to advancing medical science, especially in the fields of public health, neurodegeneration, and biochemistry.

Research Focus:

Dr. Shahangir Biswas’s research focuses on the molecular basis of disease, global health burden, neurodegeneration, and biomedical intervention strategies. He has contributed significantly to the Global Burden of Disease (GBD) Study, publishing extensively on cancer, cardiovascular diseases, and immunization trends. His work integrates biochemistry, biotechnology, and public health, aiming to identify mechanistic pathways of diseases like Alzheimer’s and tuberculosis, and develop therapeutic interventions. Additionally, he explores snake venom biochemistry, vaccine development, and the impact of social factors such as social media on mental health. Dr. Biswas is passionate about interdisciplinary research combining molecular diagnostics, bioinformatics, and global epidemiological data. His current work includes identifying biomarkers, assessing toxicology impacts, and predicting future disease trends using large-scale datasets. With over 48 peer-reviewed publications, he maintains a strong collaboration network internationally and is a vocal advocate for translational research that informs policy and clinical practice.

Publications Top Notes: 

  1. The global, regional, and national burden of cancer, 1990–2023 – The Lancet

  2. The global burden of cancer: Forecasts to 2050 – The Lancet, Accepted

  3. Global trends in childhood vaccination coverage 1980–2023 – The Lancet, Accepted

  4. Burden of Cardiovascular Diseases in 204 countries (1990–2023) – JACC, Accepted

  5. Biochemical Profile of Bangladeshi Russell’s Viper Venom – Journal of Toxicology, Accepted

  6. Neurodegeneration in Alzheimer’s Disease: Mechanisms and Therapies – Advanced Neurology, Accepted

  7. Musculoskeletal Extrapulmonary TB in Lagos, Nigeria – Health Sci Rep, Accepted

  8. Cytokines and Vascular Inflammation in Viral Infections – Health Sci Rep, Accepted 2

  9. Social Media and Mental Health of Young Adults in Bangladesh – Health Sci Rep, Accepted

  10.  Emerging Evidence on HKU5-CoV-2 – Romanian Journal of Infectious Diseases

Conclusion:

In conclusion, Dr. Mohammad Shahangir Biswas is a highly suitable candidate for the Best Researcher Award, given his consistent and impactful contributions to biomedical and public health research, his impressive publication record in world-renowned journals, and his strong academic foundation. He has demonstrated a deep commitment to advancing scientific knowledge with global relevance and interdisciplinary reach. With continued strategic focus on leadership roles in research, mentorship, and innovation, Dr. Biswas is well-positioned not only to receive this award but also to make even greater contributions to science and society in the years ahead.